$3.74 Billion is the total value of Candriam S.C.A.'s 553 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEWMONT MINING CORPnote 1.625% 7/1 | $9,963,000 | +0.1% | 10,000 | 0.0% | 0.27% | +9.4% | ||
| IYR | ISHARES TRu.s. real es etf | $5,476,000 | +5.9% | 72,900 | 0.0% | 0.15% | +15.0% | |
| SGEN | SEATTLE GENETICS INC | $5,058,000 | +16.4% | 112,700 | 0.0% | 0.14% | +26.2% | |
| EWC | ISHARESmsci cda etf | $4,883,000 | -6.5% | 227,136 | 0.0% | 0.13% | +2.3% | |
| ACHN | ACHILLION PHARMACEUTICALS IN | $3,715,000 | +56.2% | 344,300 | 0.0% | 0.10% | +70.7% | |
| IMGN | IMMUNOGEN INC | $3,231,000 | +41.3% | 238,100 | 0.0% | 0.09% | +53.6% | |
| ARES CAP CORPnote 4.375% 1/1 | $3,047,000 | -3.1% | 3,000 | 0.0% | 0.08% | +6.5% | ||
| AGIO | AGIOS PHARMACEUTICALS INC | $3,025,000 | -8.1% | 46,600 | 0.0% | 0.08% | 0.0% | |
| MDCO | MEDICINES CO | $2,364,000 | -1.6% | 63,300 | 0.0% | 0.06% | +6.8% | |
| AGEN | AGENUS INC | $2,078,000 | -1.3% | 457,700 | 0.0% | 0.06% | +7.7% | |
| INFI | INFINITY PHARMACEUTICALS INC | $1,891,000 | -7.1% | 240,900 | 0.0% | 0.05% | +2.0% | |
| CTIC | CTI BIOPHARMA CORP | $1,863,000 | -15.8% | 1,515,000 | 0.0% | 0.05% | -7.4% | |
| MACK | MERRIMACK PHARMACEUTICALS IN | $1,820,000 | -7.2% | 230,400 | 0.0% | 0.05% | +2.1% | |
| ZGNX | ZOGENIX INC | $1,679,000 | +9.2% | 113,900 | 0.0% | 0.04% | +18.4% | |
| CALA | CALITHERA BIOSCIENCES INC | $1,494,000 | +41.1% | 194,999 | 0.0% | 0.04% | +53.8% | |
| TRILLIUM THERAPEUTICS INC | $1,373,000 | +1.4% | 110,000 | 0.0% | 0.04% | +12.1% | ||
| GLYC | GLYCOMIMETICS INC | $1,258,000 | +2.1% | 220,000 | 0.0% | 0.03% | +13.3% | |
| DNAI | PRONAI THERAPEUTICS INC | $1,071,000 | -26.7% | 71,200 | 0.0% | 0.03% | -19.4% | |
| CRY | CRYOLIFE INC | $927,000 | +10.8% | 86,000 | 0.0% | 0.02% | +19.0% | |
| RDHL | REDHILL BIOPHARMA LTDsponsored ads | $914,000 | -0.7% | 71,267 | 0.0% | 0.02% | +4.3% | |
| ZFGN | ZAFGEN INC | $757,000 | -80.3% | 120,400 | 0.0% | 0.02% | -78.7% | |
| SPLK | SPLUNK INC | $747,000 | +6.3% | 12,700 | 0.0% | 0.02% | +17.6% | |
| TNXP | TONIX PHARMACEUTICALS HLDG C | $529,000 | +44.9% | 69,000 | 0.0% | 0.01% | +55.6% | |
| HSY | HERSHEY CO | $482,000 | -2.8% | 5,395 | 0.0% | 0.01% | +8.3% | |
| GNMK | GENMARK DIAGNOSTICS INC | $349,000 | -1.4% | 45,000 | 0.0% | 0.01% | 0.0% | |
| IAC | IAC INTERACTIVECORP | $324,000 | -8.0% | 5,400 | 0.0% | 0.01% | 0.0% | |
| SNDK | SANDISK CORP | $298,000 | +39.9% | 3,917 | 0.0% | 0.01% | +60.0% | |
| BG | BUNGE LIMITED | $285,000 | -6.9% | 4,172 | 0.0% | 0.01% | 0.0% | |
| SLAB | SILICON LABORATORIES INC | $277,000 | +16.9% | 5,700 | 0.0% | 0.01% | +16.7% | |
| EWH | ISHARESmsci hong kg etf | $199,000 | +3.6% | 10,017 | 0.0% | 0.01% | 0.0% | |
| NAVI | NAVIENT CORP | $132,000 | +2.3% | 11,501 | 0.0% | 0.00% | +33.3% | |
| TGA | TRANSGLOBE ENERGY CORP | $90,000 | -30.8% | 50,000 | 0.0% | 0.00% | -33.3% | |
| PBR | PETROLEO BRASILEIRO SA PETROsponsored adr | $90,000 | -1.1% | 20,920 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-01-25
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 39 | Q2 2024 | 6.7% |
| MERCK & CO INC NEW | 39 | Q2 2024 | 2.6% |
| GILEAD SCIENCES INC | 39 | Q2 2024 | 3.1% |
| REGENERON PHARMACEUTICALS | 39 | Q2 2024 | 2.0% |
| PROCTER & GAMBLE CO | 39 | Q2 2024 | 1.9% |
| JOHNSON & JOHNSON | 39 | Q2 2024 | 2.5% |
| BIOGEN INC | 39 | Q2 2024 | 2.6% |
| VERTEX PHARMACEUTICALS INC | 39 | Q2 2024 | 2.1% |
| META PLATFORMS INC | 39 | Q2 2024 | 1.6% |
| VISA INC | 39 | Q2 2024 | 1.4% |
View Candriam S.C.A.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-16 |
| 13F-HR | 2024-08-05 |
| 13F-HR | 2024-05-06 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-03 |
View Candriam S.C.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.